![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
EVER EverQuote
- 26.455
- +0.265+1.01%
Trading Apr 1 11:01 ET
945.08MMarket Cap30.06P/E (TTM)
26.585High25.937Low68.95KVolume26.330Open26.190Pre Close1.81MTurnover0.25%Turnover Ratio30.06P/E (Static)35.72MShares30.03052wk High6.98P/B724.35MFloat Cap16.63052wk Low--Dividend TTM27.38MShs Float63.440Historical High--Div YieldTTM2.47%Amplitude4.050Historical Low26.304Avg Price1Lot Size
EverQuote Stock Forum
Sign in to post a comment
Morning Movers
Gapping Up
$EverQuote (EVER.US)$ shares surged 26% after Q4 earnings beat expectations: GAAP EPS reached $0.33 (up by $0.13) and revenue jumped 165% Y/Y to $147.45M. Q1 2025 guidance projects $155–$160M revenue, with robust growth in marketing spend and adjusted EBITDA reinforcing momentum.
$Li Auto (LI.US)$ shares jumped 13% premarket after the company unveiled its first electric SUV, the Li i8. The model quickly be...
Gapping Up
$EverQuote (EVER.US)$ shares surged 26% after Q4 earnings beat expectations: GAAP EPS reached $0.33 (up by $0.13) and revenue jumped 165% Y/Y to $147.45M. Q1 2025 guidance projects $155–$160M revenue, with robust growth in marketing spend and adjusted EBITDA reinforcing momentum.
$Li Auto (LI.US)$ shares jumped 13% premarket after the company unveiled its first electric SUV, the Li i8. The model quickly be...
26
2
7
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (pres...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (pres...
65
7
4
Investors are ignoring EverQuote's limited growth expectations, paying for exposure despite the risk. The predicted future revenues may not support a positive sentiment for long, placing investments at risk.
Insider sale below current stock price suggests they see this as a fair value, a potential negative signal. Ownership shows alignment between management and small shareholders, but past sales warn caution before buying.
B Riley Securities has upgraded EVER and QNST to Buy from Neutral, based on optimism about auto insurance recovery and EverQuote's cost-cutting measures, and decision to focus on core competency by leaving health insurance.
Gainers:
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
17
4
4
Upgrades
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
12
2
3
$Roku Inc (ROKU.US)$ Keybanc cut Roku, Inc. ROKU price target from $490 to $460
$EverQuote (EVER.US)$ JP Morgan reduced EverQuote, Inc. EVER price target from $41 to $17
$Triterras (TRIT.US)$ B. Riley Securities cut the price target on Triterras, Inc. TRIT from $9 to $5
$EverQuote (EVER.US)$ JP Morgan reduced EverQuote, Inc. EVER price target from $41 to $17
$Triterras (TRIT.US)$ B. Riley Securities cut the price target on Triterras, Inc. TRIT from $9 to $5
7
No comment yet
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Do re mi : reliable or not? it always reverse from the news
Chris Ivan Ang : i believe that MDLZ deserves the upgrade